Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Redeemable Preferred Stock and Stockholders' Equity (Unaudited)

v3.22.2.2
Consolidated Statements Of Redeemable Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
Total
Series F Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Convertible Preferred Stock
Series F Convertible Preferred Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Mezzanine Equity
Series G Redeemable Preferred Stock
Beginning balance at Dec. 31, 2020 $ 10,028,000   $ 4,000 $ 261,667,000 $ 118,000 $ (385,000) $ (251,376,000)  
Balance (in shares) at Dec. 31, 2020     3,908,000   1,000      
Conversion of Series F Convertible Preferred Stock     $ 63,000 630,000 $ (630,000)      
Conversion of Series F Convertible Preferred Stock, shares         (1,000)      
Sale of common stock 13,291,000   $ 1,000 13,290,000        
Sale of common stock, shares     560,000          
Exercise of stock option 66,000   $ 7,000 66,000        
Issuance of restricted shares 164,000   10,000 164,000        
Issuance of common stock for settlement of liability 510,000   20,000 510,000        
Deemed dividend on Series F Convertible Preferred Stock 546,000     (546,000) $ 546,000      
Stock-based compensation 2,253,000   0 2,253,000        
Issuance of stock from RSUs, net     135,000          
Exercise of common stock warrants 15,062,000   $ 1,000 15,061,000        
Exercise of common stock warrants, shares     1,429,000          
Net loss (10,879,000)           (10,879,000)  
Foreign currency translation adjustments (173,000)         (173,000)    
Ending balance at Sep. 30, 2021 30,322,000   $ 6,000 293,095,000 34,000 (558,000) (262,255,000)  
Ending Balance (in shares) at Sep. 30, 2021     6,132,000          
Beginning balance at Jun. 30, 2021 33,256,000   $ 6,000 292,662,000 35,000 (468,000) (258,979,000)  
Balance (in shares) at Jun. 30, 2021     6,049,000          
Conversion of Series F Convertible Preferred Stock     $ 1,000 10,000 (10,000)      
Exercise of stock option 66,000   7,000 66,000        
Issuance of restricted shares 164,000   10,000 164,000        
Deemed dividend on Series F Convertible Preferred Stock 9,000   0 (9,000) 9,000      
Stock-based compensation 192,000   $ 0 192,000        
Exercise of common stock warrants 10,000     10,000        
Exercise of common stock warrants, shares     1,000          
Net loss (3,276,000)           (3,276,000)  
Foreign currency translation adjustments (90,000)         (90,000)    
Ending balance at Sep. 30, 2021 30,322,000   $ 6,000 293,095,000 34,000 (558,000) (262,255,000)  
Ending Balance (in shares) at Sep. 30, 2021     6,132,000          
Beginning balance at Dec. 31, 2021 $ 25,208,000   $ 6,000 293,325,000 34,000 (623,000) (267,534,000)  
Balance (in shares) at Dec. 31, 2021 7,142,000   6,149,000          
Issuance of Series G Redeemable Preferred Stock, shares               154,000
Conversion of Series F Convertible Preferred Stock       251,000 (251,000)      
Conversion of Series F Convertible Preferred Stock, shares     25,000          
Sale of common stock $ 5,635,000   $ 1,000 5,634,000        
Sale of common stock, shares     679,000          
Redemption of Series G Redeemable Preferred Stock, shares               (154,000)
Deemed dividend on Series F Convertible Preferred Stock 217,000     (217,000) $ 217,000      
Stock-based compensation 1,607,000     1,607,000        
Issuance of stock from RSUs, net, shares     113,000          
Liability award reclass 596,000     596,000        
Exercise of common stock warrants, shares     178,000          
Net loss (18,773,000)           (18,773,000)  
Foreign currency translation adjustments (415,000)         (415,000)    
Ending balance at Sep. 30, 2022 $ 13,858,000   $ 7,000 301,196,000   (1,038,000) (286,307,000)  
Ending Balance (in shares) at Sep. 30, 2022 7,144,000   7,144,000          
Ending balance, shares at Sep. 30, 2022   0            
Beginning balance at Jun. 30, 2022 $ 21,615,000   $ 7,000 300,414,000   (886,000) (277,920,000)  
Balance (in shares) at Jun. 30, 2022     6,857,000          
Sale of common stock (214,000)     (214,000)        
Deemed dividend on Series F Convertible Preferred Stock 0              
Stock-based compensation 996,000     996,000        
Issuance of stock from RSUs, net, shares     109,000          
Exercise of common stock warrants, shares     178,000          
Net loss (8,387,000)           (8,387,000)  
Foreign currency translation adjustments (152,000)         (152,000)    
Ending balance at Sep. 30, 2022 $ 13,858,000   $ 7,000 $ 301,196,000   $ (1,038,000) $ (286,307,000)  
Ending Balance (in shares) at Sep. 30, 2022 7,144,000   7,144,000          
Ending balance, shares at Sep. 30, 2022   0